About us
AllaChem was founded March 19, 2004 by Alexandre V. Ivachtchenko, Dr. Chem.Sci. and Professor. He is also an Honored Inventor of Russia, winner of the State Prize of the USSR and the Prize of the Council of Ministers of the USSR, and co-author of about 500 scientific and over 250 patent publications.
AllaChem with headquarter in Hallandale Beach, Fl is managed by professionals experienced in invention, discovery and development of drugs, including drugs for treating infectious diseases, cancer and CNS disorders.
HCV Platform
AllaChem has been developing novel small molecules with improved pharmacokinetics, efficacy, and safety properties as compared to competitors’ first in class compounds.
Read moreCancer Platform
Allachem has been developing novel small molecules with improved pharmacokinetics, efficacy, and safety properties as compared to competitors’ first in class compounds.
Read moreFlu Platform
AllaChem together with ASAVI (www.asavillc.com), has been developing novel small molecules with superior efficacy and and safety properties as compared to competitors’ first in class compounds.
Read moreCNS Platform
Avineuro Pharm. Inc. (USA) and Avineuro Ltd.(Russia) under licenses of AllaChem are developing a number of drug candidates for the treatment of schizophrenia, obesity and Alzheimer’s disease.
Read moreAllaChem continues to develop drugs in close cooperation with business and scientific partners.
AllaChem emphasizes a rational approach that combines modern medicinal chemistry with streamlined pre-clinical and clinical development studies, thus allowing a fast transition to proof-of-concept product candidates.